Close Menu

NEW YORK (GenomeWeb) – Bioinformatics startup PierianDx announced today that it has partnered with Cancer Genetics to join their respective technologies into a precision oncology testing and analysis offering.

Under the alliance, the companies will combine Cancer Genetics' Focus::NGS tests — which use next-generation sequencing to provide insights into the genetics underlying solid tumors and hematologic malignancies — with PierianDx's Clinical Genomics WorkSpace software for NGS data management.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
27
Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.